TheraNews
Subscribe

Archive summary Clinical & research

Ozempic in Schizophrenia; Psychiatrist Talks Euthanasia; New Opioid Threat

(MedPage Today) -- In overweight, prediabetic schizophrenia patients on second-generation antipsychotics, semaglutide (Ozempic) significantly improved insulin sensitivity, fasting glucose, and weight. (Diabetes Care) Experts weighed in on whether...

Summary of reporting by medpagetoday 1 min read Markdown

Newsletter

The weekly digest

Weekly digest of US behavioral health policy and regulation, source-linked and practitioner-edited. Free; unsubscribe in one click.